LRP5 and osteoporosis: Inactivating mutations of LRP5 induce the osteoporosis-pseudoglioma syndrome in humans [6], whereas gain-of-function mutations of LRP5 result in a high bone mass phenotype because of increased osteoblast activity [7], [8].